Genetic ablation of pericyte α6β1-integrin correlates with reduced pericyte investment to tumour blood vessels, changes in BM architecture and reduced PDGFRβ expression levels and PDGF-BB-mediated downstream signalling. Here, PDGFRB is linked to neoplasm.